Non-Small-Cell Lung
Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
... Lung cancer represents the leading cause of cancer related death for both men and women, and even in early stages outcomes remain poor [1]. Despite optimal surgical treatment more than 20% of patients designated ...
14
Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer
... Lung cancer (LC) is the leading cause of cancer death in both sexes, and is responsible for more than one-quarter (27%) of all cancer deaths [1]. According to recent data, LC accounted for approximately 13% of new ...
19
Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report.
... 13. Novello S, Kaiser R, Mellemgaard A, Douillard JY, Orlov S, Kr- zakowski M, et al. Analysis of patient-reported outcomes from the LUME-Lung 1 trial: a randomised, double-blind, placebo-contro- lled, Phase III ...
12
Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer.
... advanced non-small cell lung cancer (NSCLC), additional maintenance chemotherapy may be given after initial induction chemotherapy in patients who did not progress during the initial ...
8
Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer.
... The increase in MOS over this 12- year period was 0.384 months per year (1.670 weeks/year, assuming 1 month = 4.348 weeks), which is higher than the increase reported in the review of phase III trials on NSCLC by ...
8
Survival, classifications, and desmosomal plaque genes in non-small cell lung cancer.
... Morphology-based lung cancer diagnosis can be inadequate because of the lack of typical morphologic features for early-TNM-stage ...with lung cancer development and progression and can offer insights into ...
8
Therapies based on inhibitors of the epidermal growth factor receptor: reaching for the future Arlhee Daz , Agustn Lage
... carcinoma, non small-cell lung car- cinoma, and head and neck squamous cell carcinomas; the results showed that the mAb, whether administered as a monotherapy or in combination with ...
9
Infecciones por papilomavirus humanos (VPH) 16/18 en pacientes con cáncer pulmonar en México
... 39 non-small cell lung cancer specimens were exam- ined, 14 from female patients and 25 from male ...several lung pathologies, such as samples of thoracic surgery, bronchoscopic biopsy, ...
81
Vol. 59, No. 2 (2020)
... 19. Hoeijmakers F, Heineman DJ, Beck N, Klamer J, Tollenaar R, Wouters M, et al. Mediastinoscopy for Staging of Non-Small Cell Lung Cancer: Surgical Performance in The Netherlands. Ann Thorac ...
19
Propuestas para la prevencin de cncer de pulmn en el sistema de salud en Mxico
... 13. Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003;21(5):921-926. 14. ...
5
Radioterapia estereotáxica (SBRT) en el carcinoma no microcítico de pulmón (CNMP) localizado
... stage non-small cell lung cancer (NSCLC), particularly for patients who are unable to tolerate surgical resection, and possibly as an alternative to surgery for some appropriately se- lected ...
6
Inmunoterapia en pacientes con cáncer de pulmón de células no pequeñas versus terapia convencional. Revisión sistemática
... (Non- Small-cell lung cancer NSCLC) representa el 85% de todos los cánceres de pulmón y en un 40% es diagnosticado tardíamente y con los tratamientos disponibles actualmente (cirugía, ...
58
![Exactitud de la TC de Perfusión en comparación con la PET TC en el estudio de las Adenopatías Mediastínicas sospechosas de malignidad / tesis doctoral presentada por Manuel Modesto Alapont ; dirigida por Carlos Casillas Meléndez [y] Enrique Cases Viedma](https://thumb-us.123doks.com/thumbv2/123dok_es/3166016.577581/cover.webp)
Exactitud de la TC de Perfusión en comparación con la PET TC en el estudio de las Adenopatías Mediastínicas sospechosas de malignidad / tesis doctoral presentada por Manuel Modesto Alapont ; dirigida por Carlos Casillas Meléndez [y] Enrique Cases Viedma
... Real‐time endobronchial ultrasound‐guided transbronchial needle aspiration in mediastinal staging of non‐small cell lung cancer: how many aspirations per target lymph node station?. Ches[r] ...
245
Manejo quirrgico del cncer de pulmn Hechos y algunas reflexiones
... II non-small cell lung cancer (NSCLC) should be resected, but there is mounting evidence for the use of preoperative induction and postope - rative adjuvant therapy in stages IB and II, as ...
5
Factores que influyen en la demora diagnstica de la neoplasia de pulmn en egresados vivos
... Staging Non-small Cell Lung Cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice ...
7
Perfil mutacional por secuenciacin de nueva generacin en cncer de pulmn de clulas no pequeas en poblacin mexicana
... Objective. Targeted next-generation sequencing (t-NGS) has revolutionized clinical diagnosis allowing multiplexed de- tection of genomic alterations. This study evaluated the profile of somatic mutations by t-NGS in ...
10
2017.02.01.3
... CIMAvaxEGF is a therapeutic cancer vaccine developed in Cuba and fully licensed in the country for use in adult patients with lung cancer non-small cell (NSCLC) in stage IIIB / IV. The aims ...
7
Variability of apparent diffusion coefficients in metastatic small cell lung carcinoma: comparisons between within normal tissue and liver metastases
... In our case, the ADC values were not helpful to discriminate between normal liver and metastatic le- sions in the baseline evaluation, however it depicted significant differences in the follow-up that would allow ...
6
La transferencia nuclear y la polémica sobre el embrión humano: una actualización del debate
... When the notion of somatic cell nuclear transfer comes to our mind we usually associate it with cloning or the creation of human stem cells. In fact, in the last years, this biotechnology has been the subject of a ...
10
Immunotherapy for the Treatment of Cancer pdf
... "Cell therapy" (“Cell Transfer Technique”, as Steven Rosenberg commonly referred to it) should not be confused with another relatively novel anti-cancer strategy, named PL1-ligand inhibitors" ...
8
